HSBC Holdings
STRO icon

HSBC Holdings’s Sutro Biopharma STRO Stock Holding History

HSBC Holdings’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+6,234
New +$194K ﹤0.01% 2691
2025
Q3 		– Sell
-2,474
Closed -$18.1K – 3112
2025
Q2 		$18.1K Sell
2,474
-3,572
-59% -$29.2K ﹤0.01% 2982
2025
Q1 		$40.3K Sell
6,046
-309
-5% -$4.87K ﹤0.01% 2928
2024
Q4 		$116K Sell
6,355
-1,812
-22% -$55.3K ﹤0.01% 2863
2024
Q3 		$285K Buy
8,167
+2,081
+34% +$81.6K ﹤0.01% 2383
2024
Q2 		$173K Buy
6,086
+541
+10% +$21.4K ﹤0.01% 2607
2024
Q1 		$313K Buy
5,545
+305
+6% +$13.5K ﹤0.01% 2422
2023
Q4 		$223K Buy
5,240
+2,463
+89% +$78.2K ﹤0.01% 2418
2023
Q3 		$97.6K Buy
+2,777
New +$121K ﹤0.01% 2555
2023
Q2 		– Sell
-1,941
Closed -$87.5K – 2741
2023
Q1 		$87.5K Buy
1,941
+145
+8% +$9.2K ﹤0.01% 2521
2022
Q4 		$139K Buy
1,796
+383
+27% +$26.6K ﹤0.01% 2852
2022
Q3 		$79K Buy
1,413
+157
+13% +$9.29K ﹤0.01% 2774
2022
Q2 		$66K Buy
+1,256
New +$70.2K ﹤0.01% 3105
2020
Q4 		– Sell
-1,614
Closed -$165K – 3140
2020
Q3 		$165K Buy
+1,614
New +$152K ﹤0.01% 2521
2019
Q4 		– Sell
-1,796
Closed -$163K – 3181
2019
Q3 		$163K Buy
+1,796
New +$181K ﹤0.01% 2914

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

HSBC Holdings's STRO Position: Q2 2026 in Review

HSBC Holdings opened a new position in Sutro Biopharma (STRO) in Q2 2026: 6,234 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #2691 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in STRO as recently as Q2 2025.

HSBC Holdings first reported a position in STRO in Q3 2019 and has held it in 15 quarters since. The position peaked at $313K in Q1 2024. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • HSBC Holdings held 6,234 shares of Sutro Biopharma worth $206K as of Q2 2026.
  • Sutro Biopharma was a new HSBC Holdings position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2691 holding.
  • HSBC Holdings first reported a position in Sutro Biopharma in Q3 2019 and has held it in 15 quarters since.
  • HSBC Holdings's Sutro Biopharma position peaked at $313K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.